| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 1e-05 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.0001 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |